Park, W., Chawla, A. & O’Reilly, E. M. Pancreatic Cancer: A Review. JAMA 326, 851–862 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Von Hoff, D. D. et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N. Engl. J. Med. 369, 1691–1703 (2013).

Article  Google Scholar 

Conroy, T. et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N. Engl. J. Med. 364, 1817–1825 (2011).

Article  CAS  PubMed  Google Scholar 

Wainberg, Z. A. et al. NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial. Lancet 402, 1272–1281 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prakash, J. & Shaked, Y. The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics. Cancer Discov. 14, 1375–1388 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caligiuri, G. & Tuveson, D. A. Activated fibroblasts in cancer: Perspectives and challenges. Cancer Cell 41, 434–449 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sherman, M. H. & Beatty, G. L. Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance. Annu. Rev. Pathol. 18, 123–148 (2023).

Article  CAS  PubMed  Google Scholar 

Liudahl, S. M. et al. Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome. Cancer Discov. 11, 2014–2031 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Dias Costa, A. et al. Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer. Clin. Cancer Res. 28, 5167–5179 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grünwald, B. T. et al. Spatially confined sub-tumor microenvironments in pancreatic cancer. Cell 184, 5577–5592 (2021).

Article  PubMed  Google Scholar 

Sussman, J. H. et al. Multiplexed Imaging Mass Cytometry Analysis Characterizes the Vascular Niche in Pancreatic Cancer. Cancer Res. 84, 2364–2376 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Olive, K. P. et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457–1461 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Provenzano, P. P. et al. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell 21, 418–429 (2012).

Feig, C. et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc. Natl Acad. Sci. USA 110, 20212–20217 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rhim, A. D. et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 25, 735–747 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Özdemir, B. C. et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 25, 719–734 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Chen, Y. et al. Type I collagen deletion in αSMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. Cancer Cell 39, 548–565 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhattacharjee, S. et al. Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. J. Clin. Invest. https://doi.org/10.1172/jci146987 (2021).

Liu, X., Iovanna, J. & Santofimia-Castaño, P. Stroma-targeting strategies in pancreatic cancer: a double-edged sword. J. Physiol. Biochem. 79, 213–222 (2023).

Article  PubMed  Google Scholar 

Chakkera, M., Foote, J. B., Farran, B. & Nagaraju, G. P. Breaking the stromal barrier in pancreatic cancer: advances and challenges. Biochim. Biophys. Acta Rev. Cancer 1879, 189065 (2024).

Article  CAS  PubMed  Google Scholar 

Elyada, E. et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 9, 1102–1123 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carpenter, E. S. et al. Analysis of donor pancreata defines the transcriptomic signature and microenvironment of early neoplastic lesions. Cancer Discov. 13, 1324–1345 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bell, A. T. F. et al. PanIN and CAF transitions in pancreatic carcinogenesis revealed with spatial data integration. Cell Syst. https://doi.org/10.1016/j.cels.2024.07.001 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Sherman, M. H. et al. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. Cell 159, 80–93 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hosein, A. N., Dougan, S. K., Aguirre, A. J. & Maitra, A. Translational advances in pancreatic ductal adenocarcinoma therapy. Nat. Cancer 3, 272–286 (2022).

Article  PubMed  Google Scholar 

Fleet, J. C., Burcham, G. N., Calvert, R. D., Elzey, B. D. & Ratliff, T. L. 1α, 25 Dihydroxyvitamin D (1,25(OH)(2)D) inhibits the T cell suppressive function of myeloid derived suppressor cells (MDSC). J. Steroid Biochem. Mol. Biol. 198, 105557 (2020).

Article  CAS  PubMed  Google Scholar 

Kim, H. et al. Calcipotriol, a synthetic vitamin D analog, promotes antitumor immunity via CD4+T-dependent CTL/NK cell activation. Biomed. Pharmacother. 154, 113553 (2022).

Article  CAS  PubMed  Google Scholar 

Li, P. et al. 1α,25(OH)(2)D(3) reverses exhaustion and enhances antitumor immunity of human cytotoxic T cells. J. Immunother. Cancer https://doi.org/10.1136/jitc-2021-003477 (2022).

Giampazolias, E. et al. Vitamin D regulates microbiome-dependent cancer immunity. Science 384, 428–437 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Collisson, E. A. et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 17, 500–503 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moffitt, R. A. et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. 47, 1168–1178 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531, 47–52 (2016).

Article  CAS  PubMed  Google Scholar